ALTO NEUROSCIENCE INC (ANRO) Forecast, Price Target & Analyst Ratings

NYSE:ANRO • US02157Q1094

Current stock price

20.19 USD
+0.17 (+0.85%)
At close:
20.05 USD
-0.14 (-0.69%)
Pre-Market:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ALTO NEUROSCIENCE INC (ANRO).

Forecast Snapshot

Consensus Price Target

Price Target
$31.88
+ 57.88% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q1 / 2026
EPS Estimate
-$0.54
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
86.25%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$31.88
Upside
+ 57.88%
From current price of $20.19 to mean target of $31.88, Based on 16 analyst forecasts
Low
$13.13
Median
$29.58
High
$52.50

Price Target Revisions

1 Month
0.40%
3 Months
6.84%

Price Target Summary

16 Wall Street analysts provided a forecast for the next 12 months for ANRO. The average price target is 31.88 USD. This implies a price increase of 57.88% is expected in the next year compared to the current price of 20.19.
The average price target has been revised upward by 6.84% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ANRO Current Analyst RatingANRO Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

ANRO Historical Analyst RatingsANRO Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
86.25%
ANRO was analyzed by 16 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about ANRO.
In the previous month the buy percentage consensus was at a similar level.
ANRO was analyzed by 16 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-18BairdMaintains Outperform -> Outperform
2026-03-17Chardan CapitalMaintains Buy -> Buy
2026-03-17WedbushMaintains Neutral -> Neutral
2026-02-17BTIGMaintains Buy -> Buy
2026-01-05Chardan CapitalMaintains Buy -> Buy
2025-11-17BTIGInitiate Buy
2025-11-13BairdMaintains Outperform -> Outperform
2025-11-12JefferiesMaintains Buy -> Buy
2025-10-24HC Wainwright & Co.Maintains Buy -> Buy
2025-10-20BairdMaintains Outperform -> Outperform
2025-09-29Chardan CapitalInitiate Buy
2025-08-18HC Wainwright & Co.Reiterate Buy -> Buy
2025-06-26HC Wainwright & Co.Reiterate Buy -> Buy
2025-05-15WedbushReiterate Neutral -> Neutral
2025-04-07HC Wainwright & Co.Initiate Buy
2024-12-16Jones TradingInitiate Buy
2024-11-13StifelMaintains Buy -> Buy
2024-10-23WedbushDowngrade Outperform -> Neutral
2024-10-23BairdMaintains Outperform -> Outperform
2024-09-10WedbushReiterate Outperform -> Outperform
2024-09-03WedbushInitiate Outperform
2024-06-21Rodman & RenshawInitiate Buy
2024-03-25StifelReiterate Buy -> Buy
2024-02-27StifelInitiate Buy
2024-02-27BairdInitiate Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q1 / 2026
EPS Estimate
-$0.54
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
3.30%
Number of Analysts
12

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
1.46%

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ANRO revenue by date.ANRO revenue by date.
210KN/A
-100.00%		4.743M41.671M
778.58%		261.12M
526.62%		803.04M
207.54%		1.373B
70.98%		2.317B
68.75%
EBITDA
YoY % growth
ANRO ebitda by date.ANRO ebitda by date.
-11.911MN/A
-142.21%		N/A
-29.76%		N/A
-81.93%		-72.318M
-6.18%		-106.896M
-47.81%		-156.57M
-46.47%		-201.654M
-28.79%		-148.614M
26.30%		-39.372M
73.51%		N/AN/AN/A
EBIT
YoY % growth
ANRO ebit by date.ANRO ebit by date.
-12.056MN/A
-142.14%		-42.2M
-29.52%		-74.975M
-81.46%		-68.831M
-0.32%		-92.428M
-34.28%		-127.637M
-38.09%		-143.013M
-12.05%		-136.891M
4.28%		33.773M
124.67%		478.32M
1,316.28%		830.34M
73.60%		1.203B
44.88%
Operating Margin
ANRO operating margin by date.ANRO operating margin by date.
-5,740.95%N/AN/AN/AN/AN/AN/A-3,015.24%-328.50%12.93%59.56%60.48%51.92%
EPS
YoY % growth
ANRO eps by date.ANRO eps by date.
N/AN/A-4.78-2.64
46.85%		-2.29
9.06%		-2.35
-1.72%		-2.74
-16.41%		-2.98
-9.07%		-2.10
29.74%		2.18
204.14%		4.91
124.77%		6.11
24.53%		9.70
58.76%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.54
3.30%		-0.60
7.57%		-0.62
-18.40%		-0.60
-2.82%		-0.67
-22.89%		-0.71
-18.64%		-0.73
-17.79%		-0.73
-22.77%
Revenue
Q2Q % growth		N/AN/AN/AN/A
EBITDA
Q2Q % growth		-24.888M
-60.52%		-26.622M
-45.14%		-28.254M
-95.57%		-29.988M
-82.92%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-20.065M
-28.00%		-23.305M
-24.75%		-24.116M
-61.30%		-27.605M
-61.86%		-25.704M
-28.10%		-26.724M
-14.67%		-27.744M
-15.05%		-28.764M
-4.20%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ANRO Yearly Revenue VS EstimatesANRO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2028 2029 2030 2031 2032 2033 500M 1B 1.5B 2B
ANRO Yearly EPS VS EstimatesANRO Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-8.90%
EPS Next 5 Year
24.11%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-27.82%
EBIT Next 5 Year
-14.66%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ALTO NEUROSCIENCE INC / ANRO Forecast FAQ

What is the average price target for ALTO NEUROSCIENCE INC (ANRO) stock?

16 analysts have analysed ANRO and the average price target is 31.88 USD. This implies a price increase of 57.88% is expected in the next year compared to the current price of 20.19.

What are the consensus estimates for ALTO NEUROSCIENCE INC (ANRO) next earnings?

The consensus EPS estimate for the next earnings of ALTO NEUROSCIENCE INC (ANRO) is -0.54 USD and the consensus revenue estimate is 0 USD.

What is the number of analysts for ANRO stock?

The number of analysts covering ALTO NEUROSCIENCE INC (ANRO) is 16.